Treatment outcomes of esophageal squamous cell carcinoma with cM1 lymph node without organ metastasis

Dis Esophagus. 2025 Sep 1;38(5):doaf095. doi: 10.1093/dote/doaf095.ABSTRACTStage IVB esophageal cancer typically has a poor prognosis; patients with non-regional lymph-node metastasis (cM1 LYM) but no organ metastasis generally fare better. However, comprehensive reports on treatment outcomes are limited. We included 158 patients with esophageal squamous cell carcinoma (ESCC) and cM1 LYM without organ metastasis treated at our institute between October 2006 and November 2022; their treatment outcomes were assessed, and prognostic factors were evaluated. The 3-year overall survival (OS) rates for all patients and those treated with surgery, chemoradiotherapy, chemotherapy, or palliative radiotherapy were 43.7%, 60.7%, 38.5%, 22.4%, and 20.0%, respectively.…
Origen: Treatment outcomes of esophageal squamous cell carcinoma with cM1 lymph node without organ metastasis – PubMed